Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.

about

Predicting transporter-mediated drug interactions: Commentary on: "Pharmacokinetic evaluation of a drug transporter cocktail consisting of digoxin, furosemide, metformin and rosuvastatin" and "Validation of a microdose probe drug cocktail for clinic

P2860

Q39040900-2721943C-23B2-4CEC-9C3F-1204081E5E02

P2860

Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.

Item

http://www.wikidata.org/entity/Q44737065

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Evaluation of Proposed In Vivo ...... ransporter Activity in Humans.

@en

Evaluation of Proposed In Vivo ...... ransporter Activity in Humans.

@nl

type

Item

label

Evaluation of Proposed In Vivo ...... ransporter Activity in Humans.

@en

Evaluation of Proposed In Vivo ...... ransporter Activity in Humans.

@nl

prefLabel

Evaluation of Proposed In Vivo ...... ransporter Activity in Humans.

@en

Evaluation of Proposed In Vivo ...... ransporter Activity in Humans.

@nl

P1476

Evaluation of Proposed In Vivo ...... ransporter Activity in Humans.

@en

P2093

Jeremiah D Momper

http://www.w3.org/2001/XMLSchema#string

Joseph D Ma

http://www.w3.org/2001/XMLSchema#string

Shirley M Tsunoda

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Reduction of metformin renal tubular secretion by cimetidine in man

Statistical methods for assessing agreement between two methods of clinical measurement

Towards quantitation of the effects of renal impairment and probenecid inhibition on kidney uptake and efflux transporters, using physiologically based pharmacokinetic modelling and simulations

ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans

Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta

Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

P304

S82-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.736

http://www.w3.org/2001/XMLSchema#string

P478

56 Suppl 7

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27385182

http://www.w3.org/2001/XMLSchema#string

Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.

about

P2860

P2860

Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698